Pharmacoeconomic analysis of type 2 diabetes mellitus and its microvascular complications
DOI:
Abstract
The international society for pharmacoeconomics and outcomes research (ISPOR) defines “Pharmacoeconomics as the field of study that evaluates the behaviour of individuals, firms and markets relevant to the use of pharmaceutical products, services and programs and which frequently focuses on the costs (inputs) and consequences (outcomes) of that use”. It is the description and analysis of the cost of drug therapy to health care systems and society. This prospective observation study was carried out for over a period of 6 months commencing from March 2014 to August 2014 among inpatients of General medicine and Nephrology departments of a tertiary care referral hospital in kerala.All diabetes mellitus patient treated in the Inpatient department of General medicine and Nephrology department during March-August 2014 were monitored, collect relevant data and entered into the data sheet. Based on the inclusion and exclusion criteria of the protocol approved by the IEC, patients belonging to the age group 40-70 of both sex were selected and enrolled for the study.
Downloads
Copyright (c) 2018 International Journal of Research in Hospital and Clinical Pharmacy
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
The author(s) acknowledged that the manuscript submitted is his/her/their own original work; all Authors participated in the work in a substantive way and are prepared to take public responsibility for the work; all authors have seen and approved the manuscript as submitted; the manuscript has not been published and is not being submitted or considered for publication elsewhere; the text, illustrations, and any other materials included in the manuscript do not infringe (plagiarism) upon any existing copyright or other rights of anyone. Not with standing the above, the Contributor(s) or, if applicable the Contributor’s Employer, retain(s) all proprietary rights other than copyright, such as Patent rights; to use, free of charge, all parts of this article for the author’s future works in books, lectures, classroom teaching or oral presentations; the right to reproduce the article for their own purposes provided the copies are not offered for sale. All persons who have made substantial contributions to the work reported in the manuscript, bu t who are not contributors, are named in the Acknowledgment and have given me/us their written permission to be named. If I/we do not include an Acknowledgment that means I/we have not received substantial contributions from non -contributors and no contributor has been omitted. Further, I/We agreed to take all the public responsibility with regard to the views expressed in the Article.
We Locate at
:+91-9703529294.
